The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 13, 2026
Filed:
Sep. 18, 2020
Bristol-myers Squibb Company, Princeton, NJ (US);
Sherif Ibrahim Farag Badawy, Dayton, NJ (US);
Jonathan R. Brown, Chester, GB;
Candice Y. Choi, Palisades Park, NJ (US);
Christoph Gesenberg, Cheshire, CT (US);
Vivienne Gray, Barnston, GB;
John Wynne Jones, Mwynglawdd, GB;
Umesh Kestur, North Brunswick, NJ (US);
Balvinder S. Vig, Milltown, NJ (US);
Xiaotian S. Yin, Kendall Park, NJ (US);
Christopher A. Zordan, East Brunswick, NJ (US);
Corey Bloom, Bend, OR (US);
Ian Yates, Bend, OR (US);
Bristol-Myers Squibb Company, Princeton, NJ (US);
Abstract
Stable and bioavailable formulations and dosage forms comprising a dispersion (e.g., spray-dried dispersion) of solid amorphous 6-(cyclopropancamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide (Formula (I): BMS-986165) in a solid polymer matrix are provided for the treatment of auto-immune and auto-inflammatory diseases such as an inflammatory bowel disease (IBD) and psoriasis.